ROSEN, a Top Law Firm, Encourages Revance Therapeutics, Inc. Investors to Get Legal Counsel Losses Ahead of Important Securities Class Action Deadline – RVNC – QNT Press Release

[ad_1]

NEW YORK, January 16, 2022 (GLOBE NEWSWIRE) —

Why: Rosen LLP, a global investor rights law firm, reminds buyers to buy Revance Therapeutics, Inc. (NASDAQ:RVNC) during the period from November 25, 2019 to October 11, 2021 (inclusive) (“Class Period”), February 8, 2022 Lead Plaintiff Deadline.

So: If you purchased Revance securities during a class action, you may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs or costs.

What to do next: To join the Revance class action, please visit http://www.rosenlegal.com/cases-register-2179.html Or call Phillip Kim, Esq.Toll Free 866-767-3653 or email pkim@rosenlegal.com or case@rosenlegal.com Information on class action lawsuits. A class action lawsuit has been filed.If you wish to be the lead plaintiff, you must move the court No later than February 8, 2022. The lead plaintiff is the representative party directing the litigation on behalf of the other class members.

Why choose the Rosen method: Investors are encouraged to choose qualified attorneys with a successful track record in leadership positions. Often times, companies…

The full story is available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center